What is the treatment of eosinophilia?
treatment of eosinophilia depends on whether the condition is considered secondary, clonal or idiopathic. The condition can produce symptoms anywhere in the body and occurs due to an abnormal number of granulated white blood cells known as eosinophils. Secondary and clonal eosinophilia is generally reversed after the treatment of basic contributing factors. The process of idiopathic disease usually requires medicines that reduce inflammation and disrupt the growth and development of cells. When this number increases to 500 cells/dl or more, health care providers call the condition of eosinophilia. Slight cases of condition occur when eosinophils escalate to 500 to 1,500/dl. Severe cases occur when these levels overcome 1,500/dl. If patients have 1,500/dl of eosinophils for three months or more, the condition becomes hypereosinophilia.
Secondary eosinophilia occurs white blood cells to an allergic reaction, antimicrobial or parasitic infection or injury or the process of disease that causes an inflammatory response. LeafIn this case, Eosinophilia requires a solution to the basic state. Clonal eosinophilia is the body's reaction to benign or malignant growth and to hemolytic conditions that include leukemia. Removal of benign growth usually reduces the number of eosinophils. Chemotherapy and cytotoxic drugs often act as effective treatment of eosinophilia.
doctors diagnose idiopathic eosinophilia by eliminating any causal factors that may include abnormal growth, infections or inflammation of the tissue. The causes of eosinophilia include familial features and genetic mutations. As the affected blood passes through organs, eosinophils cause tissue damage in these areas. It does not cure, the disease can cause irreversible organ damage or proceed to certain types of leukemia.
Eosinophilia control generally involves the use of corticosteroids that reduce inflammation, and antineoplastic drugs, hydroxycarbamide that inhibits cell replication. LEcners can also use interferon-a, which also inhibits cell division. Some patients respond to cytotoxic inhibitor of tyrosinekinase, known as imatinib, as part of the treatment of eosinophilia. Organ damage may require reparative surgery or secondary drugs to alleviate symptoms.
symptoms differ from patient to patient, but visible symptoms of eosinophilia may include skin rashes that resemble eczema or hive. An increased amount of eosinophils in the heart can produce blood clots that relax and travel through the body, causing pulmonary embolism or stroke. Patients suffer from pain or tightening on the chest, cough and swelling in the legs and feet. Cardiac tissue can become fibrous and the valve dado to the mage. The condition can proceed to coopesting heart failure.
When it affects the lungs, eosinophilia can cause symptoms similar to respiratory infections and imaging studies can detect infiltrated or inflamed tissue. Blood clots or fibrous tissue may developUT, which further prevents respiratory skills and tissue oxygenation. Gastrointestinal symptoms of eosinophilia often involve abdominal pain accompanied by nausea, twist and diarrhea. Some patients also develop an enlarged liver and spleen. The effects of the central nervous system of the disease process include behavioral changes, a decrease in cognitive abilities, confusion and memory loss.